Pipelines

Yunovia’s pipleline targets major therapeutic areas with large unmet medical need.

Total.7

  • ID110521156 (GLP-1R agonist) Type 2 diabetes mellitus / Obesity treatment

    • Diabetes
    • 2024.09.03

  • ID120040002 (P-CAB) Gastroesophageal reflux disease treatment

    • Gastrointestinal disease
    • 2024.09.03

  • ID119040338 (A1/A2A dual adenosine receptor antagonist) Parkinson’s disease (PD) treatment

    • Brain disease
    • 2024.09.03

  • ID119031166 (FXR agonist) Metabolic dysfunction-associated steatohepatitis (MASH) treatment

    • Liver disease
    • 2024.09.03

  • ID110410395 (CFTR activator/PDE4 inhibitor) Dry eye disease treatment

    • Eye disease
    • 2024.09.03

  • IDG16177 (GPR40 agonist) Type 2 diabetes mellitus treatment

    • Diabetes
    • 2024.09.03

  • ID119050134 (Autotaxin inhibitor) Liver cirrhosis treatment

    • Liver disease
    • 2023.11.21